Polichemioterapia Neo-Adiuvante Con M-Vec Nel Carcinoma Vescicale Di Stadio Avanzato

Bonadonna G. : Principi clinici di chemioterapia antitumorale. In: Manuale di Oncologia Medica, Bonadonna G. e Robustelli Delia Cuna G. 0 (eds), Cap. 16:31245; Masson ed., Milano 1987.

Bush H. , Thatcher N. Barnard R. : Chemotherapy in the management of invasive bladder cancer. A review. Cancer Chemother. Pharmacol., 3; 87–96 (1979).

Hall R.R. , Evans R.G.B. , Pritchett G.J. , Price D.A. : Combination chemotherapy for advanced bladder cancer. Brit. J. Urol., 34; 16–19 (1982).

Marshall V.F : Relation of preoperative estimate to pathologic demonstration of extent of vesical neoplasms. J. Urol., 68; 614–723 (1952).

Meyers F.J. , Palmer J.M. , Freiha F.S. , Harker E.G. , Shortliffe L.D. , Hamingen J. , McWhirter K. , Toni F.M. : The fate of the bladder in patients with metastatic bladder cancer treated with Cisplatin, Methotrexate and Vinblastine: a Northern California Oncology Group Study. J. Urol., 134; 1118–1121 (1985).

Scher H.I. , Yagoda A. , Herr H.W. , Sternberg C.N. , Bool G. , Morse M.J. , Sogani P.C. , Watson R.C. , Dershaw D.D. , Reuter V. , Geller N. , Hollander P.S. , Vaughan E.D. jr. , Whitmore W.F. jr. , Fair W.R. : Neuadjuvant M-VAC effect on the primary bladder lesion. J. Urol., 139; 470–474 (1988).

Skinner D.G. , Daniels J.R. , Lieskowsky G. : Current status of adjuvant chemotherapy after radical cystectomy for deeply invasive bladder cancer. Urology, 24; 46–52 (1984).

Skinner D.G. , Lieskowsky G. : Management of invasive and high grade bladder cancer. In: Diagnosis and Management of Genitourinary Cancer, Skinner D.G. , Lieskowsky G. (eds), chapt. 16:295–312. W.B. Launders Co., Philadelphia 1988.

Soloway M.S. : Is there a role for induction therapy for locally advanced bladder cancer? Urology, 29; 577–583 (1987).

Sternberg C.N. , Yagoda A. , Scher H.I. : Preliminary results of M-VAC for transitional cell carcinoma of the urothelium. J. Urol., 33; 403–407 (1985).

Sternberg C.N. : M-VAC (Methotresate, Vinblastine, Doxorubicine and Cisplatinum) for advanced transitional cell carcinoma of the urothelium. J. Urol., 139; 461 (1988).

Vogelzang N.J. , Chodak G.W. , Awan A.M. , Ruane M. , Straus F.H. , Schoenberg H.W. : Neoadjuvant chemotherapy for locally invasive transitional cell carcinoma of the bladder. Proc. Amer. Ass. Cancer Res., 28; 204, abstract 809 (1987).

Yagoda A. : Chemotherapy of urothelial tract tumors. In: Bladder Cancer: Future Directions for Treatment. Yagoda A. (ed.) p. 870, John Wiley & Sons, New York 1986.

Yagoda A. : Chemotherapy of urothelial tract tumors. Cancer, 60; 1879 (1987).

Yagoda A. : Chemotherapy of advanced urothelial tract cancer: Memorial Hospital experience. Acta Urol. Ital., 1 (suppl.); 4 (1987).

Yagoda A. : Neoadjuvant chemotherapy in bladder cancer. Urology, 31; suppl. 2, 9–12 (1988).

Whitmore W.F. : Toward the rational management of the bladder cancer: an overview. Urology, 31; suppl. 2, 5–8 (1988).